Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24 16:59 | 5/1/24 | FENC | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | 3 | S.m | -1,418 | 10.78 | 0 | -132 | 276 | D | |||||||||||||||
4/22/24 19:34 | 4/19/24 | FENC | Health | BioPrd | Biological Products, (No Diag | Haigh Adrian | NC | O | COO | 3 | S.dm | -1,511 | 6.80 | 0 | -222 | -100 | 0 | D | ||||||||||||||
4/15/24 18:15 | 4/15/24 | FENC | Health | BioPrd | Biological Products, (No Diag | Rallis Chris A | NC | D | 2 | S.d | -32 | 10.83 | 0 | -3 | 46 | D | ||||||||||||||||
3/27/24 16:22 | 3/26/24 | FENC | Health | BioPrd | Biological Products, (No Diag | Andrade Robert | NC | O | CFO | 2 | S | -306 | 10.95 | 0 | -28 | 106 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |